On the contrary, RAD51-AS1 could promote the growth of tumor cells in breast cancer (Gazy et al. 2015) and OvCA (Zhang et al. 2017), but to date still little is known about molecular mechanisms by which RAD51-AS modulates OvCA progression. Here, RAD51 is linked to breast carcinoma.